Financhill
Sell
28

BDRX Quote, Financials, Valuation and Earnings

Last price:
$1.66
Seasonality move :
-21.01%
Day range:
$1.63 - $1.80
52-week range:
$1.14 - $74.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.11x
P/B ratio:
0.10x
Volume:
369.7K
Avg. volume:
3.1M
1-year change:
-92.8%
Market cap:
$1.1M
Revenue:
$474.1K
EPS (TTM):
-$74.60

Earnings Data

Next earnings date for BDRX
Apr 18
2025
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals PLC Earnings Questions

  • How Much did Biodexa Pharmaceuticals PLC Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals PLC reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals PLC Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals PLC Profitable?

    Biodexa Pharmaceuticals PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals PLC EPS Next Year?

    Biodexa Pharmaceuticals PLC's earnings are forecast to decrease from -$248.86 per share to -$0.06 per share next year representing a decrease of -99.98%.

  • When is Biodexa Pharmaceuticals PLC's Earnings Date?

    Biodexa Pharmaceuticals PLC's next earnings date is April 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Energy Transfer a Good Dividend Stock to Buy Now?
Is Energy Transfer a Good Dividend Stock to Buy Now?

Energy Transfer (NYSE:ET) offers an impressive yield, to say the…

Did the Market Bottom Already?
Did the Market Bottom Already?

The past few weeks have been among the most volatile…

Will NVIDIA Return to Its 52-Week High?
Will NVIDIA Return to Its 52-Week High?

NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
47
RGC alert for Apr 15

Regencell Bioscience Holdings [RGC] is down 11.8% over the past day.

Sell
50
SLP alert for Apr 15

Simulations Plus [SLP] is up 4.69% over the past day.

Sell
46
ZLAB alert for Apr 15

Zai Lab [ZLAB] is up 6.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock